Shenzhen Cau Technology Company Limited operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shenzhen Cau Technology Company Limited with three other
pharmaceutical manufacturers in Asia:
Cellumed Co Ltd
of South Korea
sales of 21.61 billion Korean Won [US$19.19 million]
(2.48 billion Japanese Yen [US$22.37 million]
of which 63%
was Health Inspection Equipment), and
Syn-Tech Chem. & Pharm. Co., Ltd.
based in Taiwan
(694.99 million Taiwanese Dollars [US$22.54 million]
of which 100%
was Mfg of Medicine).
During the year ended December of 2017, sales at
Shenzhen Cau Technology Company Limited were 138.61 million Chinese Renmimbi (US$20.50 million).
decrease of 50.8%
versus 2016, when the company's sales were 281.86 million Chinese Renmimbi.